EUVIMEDEUVIMED entdecken
Crossref

SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories

Bassant M El-Mokadem, Dalaal M Abdallah, Hanan S El-Abhar, Sarah A Abd El-Aal, Asmaa A Gomaa

Life Sciences · 2026-05 · 393 · 124339

DOI: 10.1016/j.lfs.2026.124339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life Sciences, 2026-05. Verfasst von Bassant M El-Mokadem und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Chinese University, Cairo, Egypt. Hauptthemen laut MEDLINE: Doxorubicin, Receptors, Neurokinin-1, Substance P, Wnt Signaling Pathway. Die Arbeit nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doxorubicin (Dox) is a cornerstone chemotherapeutic agent whose clinical use is limited by nephrotoxicity driven by oxidative stress, renin-angiotensin system (RAS) imbalance, activation of the profibrotic Wnt/β-catenin pathway, and suppression of the renoprotective protein α-Klotho. Substance P (SP) signaling through the neurokinin-1 (NK-1) receptor is a mediator of inflammatory injury; however, its role in Dox-induced nephrotoxicity remains unexplored. Therefore, we investigated whether pharmacological blockade of the NK-1 receptor with MK-0869 could alleviate Dox-induced nephrotoxicity and modulate α-Klotho-associated antioxidant and signaling pathways. Male Sprague-Dawley rats were assigned to control, MK-0869, Dox, and Dox + MK-0869 groups. Dox nephrotoxicity was induced cumulatively (16 mg/kg over 28 days), while MK-0869 was administered orally (10 mg/kg/day). Renal function markers, signaling and oxidative stress markers were assessed using ELISA, qRT-PCR, Western blotting, immunohistochemistry, and histopathological analysis. MK-0869 markedly attenuated Dox-induced renal injury, significantly improving renal function and histological architecture. Specifically, compared with Dox-treated rats, MK-0869 reduced serum creatinine by 53% (p < 0.0001) while restoring renal α-Klotho levels nearly two-fold (p < 0.0001). Mechanistically, NK-1 receptor blockade suppressed SP signaling, restored Ang-(1-7) levels while attenuating the Ang II/AT-1 receptor axis, activated the Nrf2/HO-1 antioxidant pathway, reinstated FoxO3a-dependent SOD2 expression, and inhibited Wnt-1/β-catenin signaling, thereby reducing renal fibrosis. In conclusion, NK-1 receptor blockade confers robust protection against Dox-induced nephrotoxicity through integrated modulation of α-Klotho signaling, RAS balance, oxidative stress, and profibrotic pathways. These findings support MK-0869 as a promising renoprotective adjunct during Dox therapy and warrant further studies to evaluate long-term safety and translational potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinReceptors, Neurokinin-1Substance PWnt Signaling PathwayRenin-Angiotensin SystemKidney DiseasesAnimalsMaleRats, Sprague-DawleyRatsOxidative StressKlotho ProteinsNeurokinin-1 Receptor AntagonistsKidneySignal TransductionAntibiotics, Antineoplasticbeta Catenin

Stichwörter der Autor:innen

DoxorubicinSubstance P/neurokinin-1 receptor axisWnt/β-cateninα-Klotho

Substanzen

DoxorubicinReceptors, Neurokinin-1Substance PKlotho ProteinsNeurokinin-1 Receptor AntagonistsAntibiotics, Antineoplasticbeta Catenin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Egyptian Chinese University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: Hanan.elabhar@pharma.cu.adu.eg.
  • Department of Pharmacy, Kut University College, Al Kut, Wasit, 52001, Iraq.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ahram Canadian University, 6(th) of October City, Giza, Egypt.

Zitieren

APA

El-Mokadem, B. M., Abdallah, D. M., El-Abhar, H. S., Abd El-Aal, S. A., & Gomaa, A. A. (2026). SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories. Life Sciences, 393, 124339. https://doi.org/10.1016/j.lfs.2026.124339

Vancouver

El-Mokadem BM, Abdallah DM, El-Abhar HS, Abd El-Aal SA, Gomaa AA. SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories. Life Sciences. 2026;393:124339. doi:10.1016/j.lfs.2026.124339

BibTeX
@article{ElMokadem2026,
  author = {El-Mokadem, Bassant M and Abdallah, Dalaal M and El-Abhar, Hanan S and Abd El-Aal, Sarah A and Gomaa, Asmaa A},
  title = {SP/NK-1 pathogenic signaling drives doxorubicin nephrotoxicity: Novel therapeutic role of MK-0869 via modulation of α-Klotho, RAS, and Wnt/β-catenin trajectories},
  journal = {Life Sciences},
  year = {2026},
  volume = {393},
  pages = {124339},
  doi = {10.1016/j.lfs.2026.124339}
}
Kostenlos starten →